Literature DB >> 31353534

Clinical factors associated with the recurrence of central giant cell lesions.

Bruno Ramos Chrcanovic1, Carolina Cavaliéri Gomes2, Thiago Rezende Dos Santos3, Mauro Henrique Nogueira Guimarães Abreu4, Ricardo Santiago Gomez5.   

Abstract

Central giant cell lesion of the jaws (CGCLJ) is a destructive condition that shows a varied and unpredictable biological behaviour. In the present study, we aimed to evaluate factors associated with the recurrence of CGCLJ. Based on the data of a previous systematic review of 2270 cases of CGCLJ, we used the multiple imputation to deal with the missing data. The dependent variable was the recurrence after the first treatment (yes/no). The dichotomic covariates were sex, upper or lower jaw location, size (up to or larger than 4 cm), pain, cortical bone perforation (yes/no), locularity (uni-/multilocular), tooth displacement (yes/no), treatment type (curettage or enucleation) and root resorption (yes/no). The final logistic model indicated that the tumours associated with tooth displacement, root resorption and treated with curettage had a more significant chance of recurrence. In conclusion, our study suggests that tooth displacement, root resorption and the type of treatment are potentially useful in the future construction of an algorithm for patient's treatment.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  bone disease; central giant cell granuloma; central giant cell lesion; clinical features; recurrence rate; treatment

Mesh:

Year:  2019        PMID: 31353534     DOI: 10.1111/jop.12937

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  5 in total

1.  Neurofibromatosis Type 1 With Cherubism-like Phenotype, Multiple Osteolytic Bone Lesions of Lower Extremities, and Alagille-syndrome: Case Report With Literature Survey.

Authors:  Reinhard E Friedrich; Jozef Zustin; Andreas M Luebke; Thorsten Rosenbaum; Martin Gosau; Christian Hagel; Felix K Kohlrusch; Ilse Wieland; Martin Zenker
Journal:  In Vivo       Date:  2021 May-Jun       Impact factor: 2.155

2.  Clinical and Radiologic Response of Central Giant Cell Granuloma to Denosumab: A 6-Year Prospective Observational Study.

Authors:  Yoon Ji Jina Rhou; Che-Jen Wang; Minh Nguyen; Joel A Vanderniet; Craig F Munns; Hedley Coleman; James Kim; Deborah Jane Holmes-Walker; Lydia Lim; Christian M Girgis
Journal:  Calcif Tissue Int       Date:  2022-01-28       Impact factor: 4.333

3.  Development and Validation of a Prognostic Nomogram for Postoperative Recurrence-Free Survival of Ameloblastoma.

Authors:  Yao-Cheng Yang; Jun-Jie Wang; Yun Huang; Wei-Xin Cai; Qian Tao
Journal:  Cancer Manag Res       Date:  2021-06-01       Impact factor: 3.989

4.  Treatment of a central giant cell lesion in the mandible.

Authors:  Bernardo Correia Lima; Giulianna Lima Pinheiro; Leonardo Augustus Peral Ferreira Pinto; Maria Aparecida de Albuquerque Cavalcante
Journal:  Natl J Maxillofac Surg       Date:  2021-12-13

Review 5.  Giant Cell Lesions of the Jaws Involving RASopathy Syndromes.

Authors:  Melissa Luna; Nicholas Wolsefer; Carlos-Xavier Zambrano; Ivan James Stojanov
Journal:  Acta Stomatol Croat       Date:  2022-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.